Cargando…
ALOX5AP is a new prognostic indicator in acute myeloid leukemia
BACKGROUND: The overexpression of ALOX5AP has been observed in many types of cancer and has been identified as an oncogene. However, its role in acute myeloid leukemia (AML) has not been extensively studied. This study aimed to identify the expression and methylation patterns of ALOX5AP in bone marr...
Autores principales: | Chen, Xin-Yi, Wen, Xiang-Mei, Zhao, Wei, Chu, Ming-Qiang, Gu, Yu, Huang, Hai-Hui, Yuan, Qian, Xu, Zi-Jun, Qian, Jun, Lin, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667204/ https://www.ncbi.nlm.nih.gov/pubmed/37994961 http://dx.doi.org/10.1007/s12672-023-00826-9 |
Ejemplares similares
-
The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2019) -
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021) -
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
por: Chen, Yaoyu, et al.
Publicado: (2009) -
Interrelationships between ALOX5AP Polymorphisms, Serum Leukotriene B4 Level and Risk of Acute Coronary Syndrome
por: He, Guoping, et al.
Publicado: (2014) -
Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation
por: Gu, Yu, et al.
Publicado: (2022)